Literature DB >> 10932827

Pharmacologic considerations for opiate analgesic and nonsteroidal anti-inflammatory drugs.

M G Papich1.   

Abstract

When administering opioid analgesic drugs or nonsteroidal anti-inflammatory drugs, veterinarians are often not familiar enough with the underlying pharmacology of the drugs, particularly with the potential for drug interactions and adverse effects. This article considers some of the pharmacologic features of these drugs and provides a basis for important interactions, contraindications, and adverse effects.

Mesh:

Substances:

Year:  2000        PMID: 10932827     DOI: 10.1016/s0195-5616(08)70009-3

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  5 in total

1.  An evaluation of the analgesic effects of meloxicam in addition to epidural morphine/mepivacaine in dogs undergoing cranial cruciate ligament repair.

Authors:  David Fowler; Kevin Isakow; Nigel Caulkett; Cheryl Waldner
Journal:  Can Vet J       Date:  2003-08       Impact factor: 1.008

Review 2.  Analgesic use in nonhuman primates undergoing neurosurgical procedures.

Authors:  Louis DiVincenti
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232

3.  Plasma levels of a methadone constant rate infusion and their corresponding effects on thermal and mechanical nociceptive thresholds in dogs.

Authors:  T Amon; S B R Kästner; M Kietzmann; J Tünsmeyer
Journal:  BMC Vet Res       Date:  2021-01-18       Impact factor: 2.741

Review 4.  Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease.

Authors:  Francesca De Santis; Andrea Boari; Francesco Dondi; Paolo Emidio Crisi
Journal:  Animals (Basel)       Date:  2022-01-21       Impact factor: 2.752

5.  Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms.

Authors:  Constain H Salamanca; Alvaro Barrera-Ocampo; Juan C Lasso; Nathalia Camacho; Cristhian J Yarce
Journal:  Pharmaceutics       Date:  2018-09-05       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.